This qualitative study examined experiences of adults requesting genetic-carrier testingforfour autosomal-recessive and X-linked-recessive disorders. The sample consisted of 34 adults with a positive family history or membership in an ethnic group at risk for the inherited disorder A semistructured interview guide was used to collect data during an interview I month after receipt of test results. Noncarriers experienced benefits of emotional relief andfreedom to move ahead with reproductive planning. Carriers experienced burdens of sadness and loss of reproductive expectations. Some subjects in both groups experienced difficulty disclosing results to selected family members and expressed concerns regarding disclosure of testing to insurance providers.
Get full access to this article
View all access options for this article.
References
1.
Andrews, L. B. , Fullarton, J. E., Holtzman, N. A., & Motulsky, A. G. (1994). Assessing genetic risks: Implications for health and social policy. Washington DC: National Academy Press.
2.
Billings, P. , Kohn, M., de Cuevas, M., Beckwith, J., Alper, J., & Natowicz, M. (1992). Discrimination as a consequence of genetic testing. American Journal of Human Genetics, 50, 476-482.
3.
Childs, B. , Gordis, L., Kaback, M., & Kazazian, H. (1976). Tay-Sachs screening: Social and psychological impact. American Journal of Human Genetics, 28, 550-558.
4.
Chudley, A. , & Hagerman, R. (1987). Fragile X syndrome. Journal of Pediatrics, 110(6), 821-831.
5.
Collins, F. (1992). Cystic fibrosis: Molecular biology and therapeutic implications. Science, 256, 774-779.
6.
Collins, F. (1995, April). Current state of human genetics and genetics education. Paper presented at the meeting Incorporating Genetics into Medicine and Nursing Education and Practice. The Banbury Center, Cold Spring Harbor Laboratory, New York.
7.
Committee for the Study of Inborn Errors of Metabolism . (1975). Genetic screening: Programs, principles, and research. Washington, DC: National Academy of Sciences.
8.
Dubowitz, V. (1989). The Duchenne dystrophy story: From phenotype to gene to potential treatment. Journal of Child Neurology, 4, 240-250.
9.
Fanos, J. , & Johnson, J. (1993). Barriers to carrier testing for CF siblings. American Journal of Human Genetics, 53(3, Suppl.), 51-51.
10.
Fanos, J. , & Johnson, J. (1994). CF carrier status: The importance of not knowing. American Journal of Human Genetics, 55(3, Suppl.), A292-A292.
11.
Markel, H. (1992). The stigma of disease: Implications of genetic screening. The American Journal of Medicine, 93, 209-215.
12.
Marteau, T. M. , van Duijn. M., & Ellis, I. (1992). Effects of genetic screening on perceptions of health: A pilot study. Journal of Medical Genetics, 29, 24-26.
13.
Patterson, J. , & Garwick, A. (1994). Levels of meaning in family stress theory. Family Process, 33,287-304.
14.
Rutkow, I. M. , & Lipton, J. M. (1974). Some negative aspects of state health departments' policies related to screening for sickle cell anemia. American Joumal of Public Health, 64, 217-221.
15.
Skirton, H. (1995). Psychological implications of advances in genetics-I carrier testing. Professional Nurse, 10(8), 496-498.
16.
Verkerk, A. , Pieretti, M., Sutcliffe, J., Fu, Y.,Kuhl, D., Pizzuti, A., Reiner, O. Richards, S., Victoria, M., Zhang, F, Eussen, B., Van Omenn, G., Bonden, L., Riggins, G., Chastain, J. Kunst, C., Galjaard, H., Caskey, C., Nelson, D., Oostra, B., & Warren, S. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
17.
Whitten, C. F. (1973). Sickle cell programming-an imperiled promise. New England Journal of Medicine, 288, 312-319.
18.
Wilfond, B. , & Fost, N. (1990). The cystic fibrosis gene: Medical and social implications for heterozygote detection. JAMA, 263, 2777-2783.
19.
Wise, C. , Plowfield, L., Kahn, D., & Steeves, R. (1992). Using a grid for interpreting and presenting qualitative data. Western Journal of Nursing Research, 14(6), 796-800.
20.
Wooldridge, E. Q. , & Murray, R. F. (1989). The health orientation scale: A measure of feelings about sickle cell trait. Social Biology, 35(1-2), 123-136.
21.
Zeesman, S. , Clow, C., Cartier, L., & Scriver, C. (1984). A private view of heterozygosity: Eight-year follow-up study of carriers of the Tay-Sachs gene detected by high school screening in Montreal. Amencan Journal of Human Genetics, 18, 769-778.
